https://scholars.lib.ntu.edu.tw/handle/123456789/627809
Title: | Lactoferrin as potential preventative and adjunct treatment for COVID-19 | Authors: | Chang, Raymond Ng, Tzi Bun WEI-ZEN SUN |
Keywords: | Antiviral; COVID-19; Lactoferrin; SARS-CoV-2; Viral prophylaxis | Issue Date: | Sep-2020 | Publisher: | ELSEVIER | Journal Volume: | 56 | Journal Issue: | 3 | Source: | International journal of antimicrobial agents | Abstract: | The coronavirus disease 2019 (COVID-19) pandemic is rapidly advancing across the globe despite drastic public and personal health measures. Antivirals and nutritional supplements have been proposed as potentially useful against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes COVID-19, but few have been clinically established. Lactoferrin (Lf) is a naturally occurring, non-toxic glycoprotein that is orally available as a nutritional supplement and has established in vitro antiviral efficacy against a wide range of viruses, including SARS-CoV, a closely related coronavirus to SARS-CoV-2. Furthermore, Lf possesses unique immunomodulatory and anti-inflammatory effects that may be especially relevant to the pathophysiology of severe COVID-19 cases. Here we review the underlying biological mechanisms of Lf as an antiviral and immune regulator, and propose its unique potential as a preventative and adjunct treatment for COVID-19. We hope that further research and development of Lf nutritional supplementation would establish its role for COVID-19. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627809 | ISSN: | 0924-8579 | DOI: | 10.1016/j.ijantimicag.2020.106118 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.